The solid tumor microenvironment and related targeting strategies: a concise review

被引:1
作者
Wang, Yingliang [1 ,2 ,3 ]
Zhou, Huimin [4 ]
Ju, Shuguang [1 ,2 ,3 ]
Dong, Xiangjun [1 ,2 ,3 ]
Zheng, Chuansheng [1 ,2 ,3 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Radiol, Wuhan, Peoples R China
[2] Hubei Key Lab Mol Imaging, Wuhan, Peoples R China
[3] Hubei Prov Clin Res Ctr Precis Radiol & Intervent, Wuhan, Peoples R China
[4] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Nucl Med, Wuhan, Peoples R China
基金
中国国家自然科学基金;
关键词
tumor microenvironment; classification; characteristic; targeting strategies; perspective; FIBROBLAST ACTIVATION PROTEIN; INTERSTITIAL FLUID PRESSURE; EFFICIENT PHOTODYNAMIC THERAPY; HYPOXIA-INDUCIBLE FACTORS; FATTY-ACID-METABOLISM; HUMAN-MELANOMA CELLS; EXTRACELLULAR-MATRIX; GLUTAMINE-METABOLISM; IN-VIVO; HEPATOCELLULAR-CARCINOMA;
D O I
10.3389/fimmu.2025.1563858
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The malignant tumor is a serious disease threatening human life. Increasing studies have confirmed that the tumor microenvironment (TME) is composed of a variety of complex components that precisely regulate the interaction of tumor cells with other components, allowing tumor cells to continue to proliferate, resist apoptosis, evade immune surveillance and clearance, and metastasis. However, the characteristics of each component and their interrelationships remain to be deeply understood. To target TME, it is necessary to deeply understand the role of various components of TME in tumor growth and search for potential therapeutic targets. Herein, we innovatively classify the TME into physical microenvironment (such as oxygen, pH, etc.), mechanical microenvironment (such as extracellular matrix, blood vessels, etc.), metabolic microenvironment (such as glucose, lipids, etc.), inflammatory microenvironment and immune microenvironment. We introduce a concise but comprehensive classification of the TME; depict the characteristics of each component in TME; summarize the existing methods for detecting each component in TME; highlight the current strategies and potential therapeutic targets for TME; discuss current challenges in presenting TME and its clinical applications; and provide our prospect on the future research direction and clinical benefits of TME.
引用
收藏
页数:20
相关论文
共 275 条
[21]  
Bruyère F, 2008, NAT METHODS, V5, P431, DOI [10.1038/nmeth.1205, 10.1038/NMETH.1205]
[22]   Hemoglobin-based oxygen carriers: from mechanisms of toxicity and clearance to rational drug design [J].
Buehler, Paul W. ;
D'Agnillo, Felice ;
Schaer, Dominik J. .
TRENDS IN MOLECULAR MEDICINE, 2010, 16 (10) :447-457
[23]   pH-Selective Cytotoxicity of pHLIP-Antimicrobial Peptide Conjugates [J].
Burns, Kelly E. ;
McCleerey, Tanner P. ;
Thevenin, Damien .
SCIENTIFIC REPORTS, 2016, 6
[24]   Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers [J].
Camorani, Simona ;
Crescenzi, Elvira ;
Gramanzini, Matteo ;
Fedele, Monica ;
Zannetti, Antonella ;
Cerchia, Laura .
SCIENTIFIC REPORTS, 2017, 7
[25]   Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy [J].
Cannarile, Michael A. ;
Weisser, Martin ;
Jacob, Wolfgang ;
Jegg, Anna-Maria ;
Ries, Carola H. ;
Ruettinger, Dominik .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
[26]   Cancer Cell Metabolism: One Hallmark, Many Faces [J].
Cantor, Jason R. ;
Sabatini, David M. .
CANCER DISCOVERY, 2012, 2 (10) :881-898
[27]   PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis [J].
Cao, RH ;
Björndahl, MA ;
Religa, P ;
Clasper, S ;
Garvin, S ;
Galter, D ;
Meister, B ;
Ikomi, F ;
Tritsaris, K ;
Dissing, S ;
Ohhashi, T ;
Jackson, DG ;
Cao, YH .
CANCER CELL, 2004, 6 (04) :333-345
[28]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[29]   Angiogenesis in health and disease [J].
Carmeliet, P .
NATURE MEDICINE, 2003, 9 (06) :653-660
[30]   Targeting macrophages: therapeutic approaches in cancer [J].
Cassetta, Luca ;
Pollard, Jeffrey W. .
NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (12) :887-904